These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27668632)

  • 1. Managed care implications of diabetic macular edema.
    Holekamp NM
    Am J Manag Care; 2016 Jul; 22(10 Suppl):s300-s306. PubMed ID: 27668632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
    Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
    Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in the pharmacotherapy of diabetic retinopathy.
    Kumar B; Gupta SK; Saxena R; Srivastava S
    J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].
    Mrugacz M; Krajewska M; Bryl A; Szuszkiewicz M
    Pol Merkur Lekarski; 2013 Jun; 34(204):351-4. PubMed ID: 23882935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor therapy for diabetic macular edema.
    Boyer DS; Hopkins JJ; Sorof J; Ehrlich JS
    Ther Adv Endocrinol Metab; 2013 Dec; 4(6):151-69. PubMed ID: 24324855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of diabetic macular edema.
    Holekamp NM
    Am J Manag Care; 2016 Jul; 22(10 Suppl):s284-s291. PubMed ID: 27668630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
    Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.
    Hirano T; Iesato Y; Toriyama Y; Imai A; Chiba D; Murata T
    J Diabetes Complications; 2014; 28(5):729-34. PubMed ID: 24795072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema.
    Brown GC; Brown MM; Turpcu A; Rajput Y
    Ophthalmology; 2015 Jul; 122(7):1416-25. PubMed ID: 25935787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.
    Ciulla TA; Amador AG; Zinman B
    Diabetes Care; 2003 Sep; 26(9):2653-64. PubMed ID: 12941734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors.
    Al-Dwairi RA; Aleshawi A; Abu-Zreig L; Al-Shorman W; Al Beiruti S; Alshami AO; Allouh MZ
    Clinicoecon Outcomes Res; 2024; 16():161-171. PubMed ID: 38505256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF].
    Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches to the management of diabetic macular edema.
    Hariprasad SM
    Am J Manag Care; 2016 Jul; 22(10 Suppl):s292-s299. PubMed ID: 27668631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroids as part of combination treatment: the future for the management of macular edema?
    Bandello F; Battaglia Parodi M; Tremolada G; Lattanzio R; De Benedetto U; Iacono P
    Ophthalmologica; 2010; 224 Suppl 1():41-5. PubMed ID: 20714180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
    Wong TY; Sun J; Kawasaki R; Ruamviboonsuk P; Gupta N; Lansingh VC; Maia M; Mathenge W; Moreker S; Muqit MMK; Resnikoff S; Verdaguer J; Zhao P; Ferris F; Aiello LP; Taylor HR
    Ophthalmology; 2018 Oct; 125(10):1608-1622. PubMed ID: 29776671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic therapies for diabetic retinopathy and diabetic macular edema.
    Rechtman E; Harris A; Garzozi HJ; Ciulla TA
    Clin Ophthalmol; 2007 Dec; 1(4):383-91. PubMed ID: 19668515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients.
    Lee SJ; Choi MG
    Metabolism; 2006 Dec; 55(12):1681-8. PubMed ID: 17142144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
    Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
    Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.